merged_progeria-dna-base-editing.txt
<question_number>1</question_number>
<answer>N/A</answer>

<question_number>2</question_number>
<answer>N/A</answer>

<other>The article does not provide specific information to directly answer either of these questions. It mentions several researchers involved in the progeria research, but does not specify who is leading the effort to apply the technology to human patients. Similarly, while the article mentions a goal to start a clinical trial within two years, it does not provide information about an expected timeline for FDA approval.</other>